Alvotech and Teva announced FDA acceptance of the Biologics License Application (BLA) for AVT05, a proposed biosimilar ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

We’ll discuss the distinct traits of psoriatic arthritis in Black patients, and the various environmental and genetic factors ...

The FDA has accepted Alvotech (ALVO) and Teva's (TEVA) applications for AVT05, their proposed biosimilar to J&J's ...

Payton Harris was going to the doctor's office for a routine health screening when they were met with unexpected news.

These findings may offer more personalized treatment and prevention recommendations for patients with psoriasis.

A new study finds no significant differences in cardiovascular and thromboembolic risks among biologics for psoriasis or ...

A recent study on psoriatic arthritis care revealed that patients and clinicians agree on key aspects of disease management ...

UCB SA (OTCMKTS:UCBJY – Get Free Report)’s stock price passed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $96.49 and traded as low as $93.22.

In 2025, more than 3 million seniors are going to save thousands of dollars because of a new spending limit on prescription drugs. It's unclear whether the Trump Administration will keep the law.